# Cohance Lifesciences Limited, Sangareddy, India – FDA Inspections

Source: https://www.keypedia.com/companies/cohance-lifesciences-limited/c01306bf-33dc-4f28-a424-11cda764a0d5

> Inspection records and compliance data for Cohance Lifesciences Limited in Sangareddy. 8 FDA inspections on record, 2 Form 483s, last inspected August 05, 2026.

---

## Details

- Name: Cohance Lifesciences Limited
- FEI Number: 1000623515
- Facility Type: Intermediate, API, and Finished Dosage Drug Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Plot Nos 262-271, Ida Pashamylaram
- City: Sangareddy
- Country Name: India
- Address: Plot Nos 262-271, Ida Pashamylaram, Sangareddy, India
- Country: India

## Related Documents

- [483 - Cohance Lifesciences Limited - 2026-08-05](https://www.keypedia.com/records/483/cohance-lifesciences-limited/bfcf14fc-793a-4afd-87c4-78a0f88f91dc) — source: FDA, date: August 5, 2026
- [FDA Inspection 1335432 - Cohance Lifesciences Limited - 2026-08-05](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/00e7a8d5-aa11-4bf5-b5d8-01dec649dd94) — source: FDA, date: August 5, 2026
- [FDA Inspection 1234405 - Cohance Lifesciences Limited - 2024-02-23](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/ef957f57-65ad-47f9-a897-5495df26de49) — classification: No Action Indicated (NAI), source: FDA, date: February 23, 2024
- FDA Inspection 1234405 - Cohance Lifesciences Limited - 2024-02-23 — classification: No Action Indicated (NAI), source: FDA, date: February 23, 2024
- FDA Inspection 1110488 - Cohance Lifesciences Limited - 2019-11-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2019
- [483 - Cohance Lifesciences Limited - 2018-02-15](https://www.keypedia.com/records/483/cohance-lifesciences-limited/4bc35ab4-88c6-46ee-9239-41e038fc07a5) — source: FDA, date: February 15, 2018
- [FDA Inspection 1041216 - Cohance Lifesciences Limited - 2018-02-15](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/c3fdedea-4c22-4b83-a805-2135836e7f2e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 15, 2018
- FDA Inspection 973825 - Cohance Lifesciences Limited - 2016-04-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 14, 2016
- FDA Inspection 854615 - Cohance Lifesciences Limited - 2013-02-08 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 8, 2013
- FDA Inspection 703269 - Cohance Lifesciences Limited - 2010-11-04 — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2010
- FDA Inspection 566534 - Cohance Lifesciences Limited - 2009-01-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 7, 2009

## Related Companies

- [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)

## Related Officers

- [June P. Page](https://www.keypedia.com/people/june-p-page/3b1ffc71-ce2e-47f5-aefe-87fd5eebc792)
- [Pharmaceutical Program Expert](https://www.keypedia.com/people/zachary-l-stamm/b729fab9-4d31-4c70-b5b3-e8b6207769c6)
- [Alan A. Rivera](https://www.keypedia.com/people/alan-a-rivera/4bec02c3-c62e-4b3a-a6ab-02c3386549bf)